JPH0570633B2 - - Google Patents

Info

Publication number
JPH0570633B2
JPH0570633B2 JP8541584A JP4158485A JPH0570633B2 JP H0570633 B2 JPH0570633 B2 JP H0570633B2 JP 8541584 A JP8541584 A JP 8541584A JP 4158485 A JP4158485 A JP 4158485A JP H0570633 B2 JPH0570633 B2 JP H0570633B2
Authority
JP
Japan
Prior art keywords
pyridyl
thiazolidinedione
methyl
benzyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP8541584A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60208980A (ja
Inventor
Kanji Meguro
Takeshi Fujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of JPS60208980A publication Critical patent/JPS60208980A/ja
Publication of JPH0570633B2 publication Critical patent/JPH0570633B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60041584A 1984-03-21 1985-03-01 チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤 Granted JPS60208980A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1984/000117 WO1985004170A1 (en) 1984-03-21 1984-03-21 Thiazolidinedione derivatives, process for their preparation, and medicinal composition containing same
WO84/00117 1984-03-21
WO84/00445 1984-09-14

Publications (2)

Publication Number Publication Date
JPS60208980A JPS60208980A (ja) 1985-10-21
JPH0570633B2 true JPH0570633B2 (ko) 1993-10-05

Family

ID=13818276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60041584A Granted JPS60208980A (ja) 1984-03-21 1985-03-01 チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤

Country Status (2)

Country Link
JP (1) JPS60208980A (ko)
WO (2) WO1985004170A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891216A (en) * 1987-04-14 1990-01-02 Alcide Corporation Disinfecting compositions and methods therefor
US5183823A (en) 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CN101454006B (zh) * 2006-03-16 2012-12-26 新陈代谢解决方案开发公司 用于治疗高血压以及用于降低血脂的噻唑烷二酮类似物
CA2646207C (en) * 2006-03-16 2016-01-19 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
JP2009530293A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー チアゾリジンジオン類似体およびグルココルチコイドアゴニストの併用療法
WO2010105048A1 (en) * 2009-03-12 2010-09-16 Metabolic Solutions Development Company Thiazolidinedione analogues
US8912335B2 (en) 2009-12-15 2014-12-16 Metabolic Solutions Development Company, Llc PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Also Published As

Publication number Publication date
WO1985004171A1 (en) 1985-09-26
JPS60208980A (ja) 1985-10-21
WO1985004170A1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
US4582839A (en) 2,4-thiazolidinediones
KR100249988B1 (ko) 티아졸리딘디온 유도체, 그의 제조방법 및 용도
US5869495A (en) Heterocyclic compounds as pharmaceutical
KR920002131B1 (ko) 타아졸리딘디온 유도체의 제조방법
US5441971A (en) Thiazolidinedione derivatives, production and use thereof
US5952509A (en) Production of benzaldehyde compounds
JPH06779B2 (ja) チアゾリジオン誘導体およびそれを含んでなる医薬組成物
WO1995017394A1 (en) Heterocyclic derivatives and their use in pharmaceuticals
JPWO2004099149A1 (ja) 2−クロロ−5−フルオロ−3−置換ピリジンまたはその塩の製造方法
US4060601A (en) Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
WO2006035459A1 (en) An improved process for the production of derivatives of thiozolidinediones and their precursors
JPH0570633B2 (ko)
JPH044312B2 (ko)
JP2825659B2 (ja) 抗ウィルス性チアゾール
HU194199B (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents
US4175085A (en) Thienothiazine derivatives
JPS6257635B2 (ko)
KR910000443B1 (ko) 할로알킬 티아졸의 제조방법 및 이 방법으로 제조한 할로알킬 티아졸
US5827865A (en) Heterocyclic compounds as pharmaceutical
WO1990011278A1 (en) Thiazole compounds and applications thereof
HU201307B (en) Process for producing alkoxy-substituted pyridine derivatives
WO1980000567A1 (en) Phosphorylethanolamine derivatives,process for preparing same,and medicinal composition containing same
JP2003261563A (ja) アミノアルコール誘導体の新規製造法
JP2004137284A (ja) 2−スルファモイル安息香酸誘導体
JPH03157376A (ja) チアゾール系化合物およびその用途

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term